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A B S T R A C T
Microbial natural products are a crucial source of bioactive molecules and unique chemical scaffolds.
Despite their importance, rediscovery of known natural products from established productive microbes
has led to declining interest, even while emergent genomic data suggest that the majority of microbial
natural products remain to be discovered. Now, new sources of microbial natural products must be
deﬁned in order to provide chemical scaffolds for the next generation of small molecules for therapeu-
tic, agricultural, and industrial purposes. In this work, we use specialized bioinformatic programs,
genetic knockouts, and comparative metabolomics to deﬁne the genus Legionella as a new source of
novel natural products. We show that Legionella spp. hold a diverse collection of biosynthetic gene
clusters for the production of polyketide and nonribosomal peptide natural products. To conﬁrm this
bioinformatic survey, we create targeted mutants of L. pneumophila and use comparative metabolomics
to identify a novel polyketide surfactant. Using spectroscopic techniques, we show that this polyketide
possesses a new chemical scaffold, and ﬁrmly demonstrate that this unexplored genus is a source for
novel natural products.
© 2016 The authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
1. Introduction
Microbial natural products have been the most important source
of chemical scaffolds and drugs for the last century.1 Culturing
random collections of bacteria and fungi isolated from the envi-
ronment led to the identiﬁcation of proliﬁc natural product producing
genera that then received extensive focus, including Streptomyces,2
Bacillus,3 Myxobacteria,4 and Cyanobacteria.5 However, this tight
focus, along with over-reliance on classical bioactivity-guided iso-
lation approaches, has led to diminishing returns from natural
products drug discovery efforts,6 resulting in the closure of most in-
dustrial natural products programs. In spite of this trend, untargeted
sequencing of bacterial genomes has revealed that biosynthetic po-
tential is much more widespread than was previously suspected,7
and that the majority of microbial natural products are still await-
ing discovery.8,9 In addition, it is now known that only a small fraction
of bacteria can be readily cultured in laboratory conditions,10 and
that many talented natural products producers were likely missed
in initial screening efforts. In light of this information, new genome-
guided discovery efforts are a promising way to reveal valuable
chemical scaffolds from previously uncharted bacteria.
Extensive studies on the biosynthesis of bacterial natural prod-
ucts have led to informatic strategies for their discovery based on
extant genomic information.11–14 Two of the most diverse and abun-
dant classes of microbial natural products, polyketides and
nonribosomal peptides, are produced by multi-enzyme assembly
lines15 – referred to as polyketide synthases (PKSs) and nonribosomal
peptide synthetases (NRPSs) respectively – that can be readily de-
tected in bacterial genomes. Genome sequencing has revealed a
number of interesting bacterial families that could be candidates
for second generation genome-guided natural products discovery
efforts. Recent examples from Clostridia,16 Eleftheria,17 and
Entotheonella18 have demonstrated that exotic bacteria that had
been challenging to culture can be a valuable resource of new
Abbreviations: LC, liquid chromatography; MS, mass spectrometry; NRPS,
nonribosomal peptide synthetase; PKS, polyketide synthase; PCA, principal com-
ponent analysis.
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molecules that were not discovered in previous random screening
efforts.
In 2004, researchers described a unique polyketide ﬂuorophore
from a species of Legionella,19 a member of the diverse Gamma
Proteobacteria that had not previously been investigated for natural
products. In its native environment, Legionella reproduces by in-
fecting environmental amebas, replicating inside a specialized
vacuole following phagocytosis.20 Legionella is also able to infect
some mammalian phagocytes, causing a pneumonia known as
Legionnaire’s disease in immunocompromised individuals. Legionella
was ﬁrst isolated following an outbreak in 1977, and was found to
require highly specialized media for growth;21,22 relatively little
remained known about the biology of this organism until the late
1990s. In part because of its relevance as a potential pathogen, a
number of Legionella genomes are now sequenced, demonstrating
a great deal of intra-genus differentiation, as well as a number of
polyketide and nonribosomal peptide biosynthetic gene clusters.
Given its niche culture requirements, relatively late discovery, and
genetic diversity, Legionella is a strong candidate for the identiﬁ-
cation of new chemical scaffolds using genome-guided discovery
efforts. In this work, we use bioinformatic tools to chart the diver-
sity of natural product biosynthetic gene clusters in Legionella,
and use targeted mutagenesis and comparative metabolomics to
reveal a novel natural product chemical scaffold from this under-
explored bacterium.
2. Material and methods
2.1. General experimental procedures
One-dimensional (1H,13C) and two-dimensional (1H-1H and 13C-
1H HMBC, HMQC, and COSY) NMR spectra were recorded on a Bruker
AVIII 700 MHz NMR spectrometer in deuterated dimethyl sulfox-
ide (Cambridge Isotope Laboratories). High-resolution MS spectra
were collected on a Thermo LTQ OrbiTrap XL mass spectrometer
(ThermoFisher Scientiﬁc, USA) with an electrospray ionization source
(ESI). LCMS data were collected using a Bruker AmazonX ion trap
mass spectrometer coupled with a Dionex UltiMate 3000 HPLC
system, using a Luna C18 column (250 mm × 4.6 mm, Phenomenex)
for analytical separations, running acetonitrile and ddH2O with 0.1%
formic acid as the mobile phase.
2.2. Strains and culture conditions
All experiments and genetic manipulations were conducted using
the genetically amenable Legionella pneumophila Philadelphia-1
variant LP02. Mutants were constructed in LP02 with or without a
pBH6119 plasmid enabling GFP-expression through an upstream
icmR promoter, maintained through complementation of LP02’s
natural thymidine auxotrophy.23 L. pneumophila was grown at 37 °C
for all liquid cultures in either BYE (10 g/L ACES, 10 g/L yeast extract,
1 g/L monosodium α-ketoglutarate, 0.4 g/L L-cysteine, 0.25 g/L ferric
pyrophosphate, 0.1 g/L thymidine, pH = 6.9) or chemically deﬁned
Legionella media (350 mg/L L-arginine, 510 mg/L L-aspartic acid,
400mg/L L-cysteine, 600mg/L L-glutamic acid, 150mg/L L-histidine,
470 mg/L L-isoleucine, 640 mg/L L-leucine, 650 mg/L L-lysine,
200 mg/L L-methionine, 350 mg/L L-phenylalanine, 115 mg/L
L-proline, 650 mg/L L-serine, 330 mg/L L-threonine, 100 mg/L
L-tryptophan, 400mg/L L-tyrosine, 480mg/L L-valine, 315mg/L am-
monium chloride, 50 mg/L sodium chloride, 20 mg/L calcium
chloride, 1.18 g/L potassium phosphate monobasic, 70 mg/L mag-
nesium sulfate, 250mg/L ferric pyrophosphate, 100mg/L thymidine,
10 g/L ACES). When visualizing sliding motility, plates were incu-
bated at 30 °C for roughly threeweeks. All media were supplemented
with 0.1 g/L thymidine to support the auxotrophy of LP02.
2.3. Comparative metabolomic analysis
To generate samples for LCMS analysis wild type, Δlpg1939,
Δlpg2186, and Δlpg2228 LP02 strains were grown in 50mL of chem-
ically deﬁned Legionella media at 37 °C for one week. Following
this, cultures were harvested by centrifugation, pellets were ex-
tracted with methanol, and supernatants were extracted with
20 g/L HP20 resin. Extracts were pooled and were subsequently
dried by rotary evaporation and resuspended in methanol (2 mL).
Samples were processed by LCMS with a 25 cm Luna C18 column
(250 mm × 4.6 mm), using water and acetonitrile with 0.1% formic
acid as the mobile phase. Acetonitrile was held at 2% for the ﬁrst
2 min, then steadily ramped to 100% by 45 min, held until 53 min,
then reset to 2% and held until 60 min, at a ﬂow rate of 1.2 mL/
min. Principal component analysis of Legionella extracts was carried
out using Bruker Daltonics Proﬁle Analysis with the following
parameters: Rt range: 3–58 min; mass range: m/z 200–1200; rect-
angular bucketing: 10 sec (Δm/z of 2); normalized by using the sum
of bucket values in the analysis. Chromatogram subtractions were
performed using Bruker Daltonics MetaboliteDetect software using
the eXpose mode to reveal differences in excess of 5-fold, with
Δm/z of 0.5 and Δt of 0.5 min.
2.4. Isolation and puriﬁcation of legionellol A
Wild type LP02 colonies from BCYE plates were inoculated into
BYE cultures (5mL) in sterile 50mL Falcon tubes and grown for two
days at 250 rpm and 37 °C. These cultures were used to inoculate
sterile 2.8 L Fernbach ﬂasks containing BYE (1.5 L). Cultures were
grown at 37 °C with shaking at 200 rpm for roughly one week or
until two days after peak melanin production. Following growth,
cells were pelleted by centrifugation at 6000 rpm for 30 min. Su-
pernatants were mixed with 20 g/L washed HP20 resin (Diaion) for
2 h at room temperature. Resinswere harvested using Buchner funnel
vacuum ﬁltration, and washed with 10%methanol to remove highly
polar melanins. Resin was eluted with excess 100% methanol which
was then dried by rotary vacuum. Extracts were resuspended in
methanol and separated by LCMS using a Luna C18 column
(250mm × 10mm)with HPLC gradewater and acetonitrile with 0.1%
formic acid as the mobile phase. To purify legionellol, acetonitrile
began at 5% for the ﬁrst 2 min, then ramped to 30% by 5 min and
held until 27 min, followed by a shallow ramp to 45% by 40 min,
followed by a wash of 100% from 42 to 52 min. Flow was main-
tained at 6 mL/min, and legionellol A eluted at 33 min.
2.5. Incorporation of 13C ornithine
To assess the origins of the modiﬁed amino acid present in the
legionellol metabolites, cultures of L. pneumophila in chemically
deﬁned media were grown for ﬁve days in the presence of 13C or-
nithine (2 mM; Cambridge Isotope Laboratories) or 12C ornithine
(2 mM). Supernatants of cultures containing 12C and 13C ornithine
were extracted with HP-20 resin and analyzed by LCMS.
2.6. Reconstitution of sliding motility
To assess whether various legionellol species were responsible
for sliding motility, legionellol A or acylated legionellol (10 μg) was
dissolved in methanol (10 μL) and added as a drop to a 0.5% agar
plate of BCYE media. After the drops of legionellol, acyl legionellol,
or methanol alone had dried, an overnight culture of LP02 Δlpg2228
was dropped (10 μL) over top of it and subsequently dried. Plates
were incubated at 28 °C for one week before imaging.
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2.7. Insertional inactivation of genes in Legionella
Targeted insertional inactivation of biosynthetic genes in LP02
was performed as previously described,24 and will be summarized
below. All primers and plasmids used in this process are de-
scribed in Table S3. If not stated explicitly, genetic manipulations
and molecular biology techniques followed those from Cold
Spring Harbor Protocols, available at http://www.molecularcloning
.com/.
In short, two neighboring 500 bp–1000 bp fragments of target
genes were cloned into pBlueScript KSII or a modiﬁed pBlueScript
KSII bearing a chloramphenicol resistance cassette, swapped with
the ampicillin resistance cassette through two ﬂanking BspHI sites.
Plasmids were digested with Xba1 and Sac1, and gene fragments
were digested with Xba1 and Kpn1, or with Sph1 and Sac1. Chlor-
amphenicol or kanamycin resistance cassettes were ampliﬁed with
ﬂanking Kpn1 and Sph1 cut sites from pRE112 or pET-28b respec-
tively. The digested plasmid, two digested gene fragments, and
resistance cassette were ligated simultaneously and transformed
into chemically competent DH5α (Invitrogen). All plasmids were
conﬁrmed by sequencing from either end of the homology arms
and resistance cassettes. To transform into Legionella, fresh colo-
nies of LP02 were re-streaked as a dime-sized patch on fresh
BCYE and 10 μL of 100 ng/μL knockout vector solution was added
on top, followed by incubation at 30 °C for 48 h. Following incuba-
tion, colonies were re-streaked onto BCYE with kanamycin or
chloramphenicol to select for transformants. Genomic integration
was conﬁrmed through PCR with primers for the resistance cas-
sette and a region of the genome just outside the homology arm.
PCR with primers for amplifying the original gene fragment was
used to verify the exclusive presence of the insertionally inacti-
vated allele.
2.8. High resolution mass spectrometry
Legionellol A was dissolved in a mixture of HPLC grade meth-
anol and water with 0.1% formic acid providing a ﬁnal concentration
of roughly 10 μg/mL. The sample was infused directly into a Thermo
LTQ OrbiTrap XL mass spectrometer running Xcaliber 2.07 and
TunePlus 2.4 SP1 at a ﬂow rate of 3 μL/min and ionized using an
electrospray ionization source. The mass spectrometer was oper-
ated in positive mode with a maximum resolution of 100,000.
The high resolution mass for legionellol A was an average of
29 scans.
Compound Molecular
formula
Calculated
m/z
Observed
m/z
Δppm
Legionellol A [M+H]+ C23H43N2O7 459.30650 459.30665 0.327 ppm
2.9. PRISM analysis of Legionella genomes
Legionella genomes were downloaded from NCBI and loaded
into PRISM12 (http://www.magarveylab.ca/prism) using standard
settings. Of the assembled genomes used in this analysis, 24 were
draft genomes and 10 were fully assembled. Polyketide and
nonribosomal peptide gene clusters were stored, annotated, and
conﬁrmed by secondary analysis using the BLAST function of
Integrated Microbial Genomes (IMG; http://img.jgi.doe.gov/), which
also checked for fragmentation resulting from incomplete genome
assemblies. A phylogenetic tree of Legionella spp. was generated
with 16S rRNA sequences collected from Legionella genomes,
using the Geneious tree builder program with Tamura-Nei as the
genetic distance model and neighbor-joining as the tree build
method.
3. Results
3.1. Bioinformatic assessment of biosynthetic potential in Legionella
To assess the diversity of polyketide and nonribosomal peptide
gene clusters present in Legionella, we proﬁled all sequenced
genomes available for this genus through our software for PRediction
Informatics for Secondary Metabolomes (PRISM;12 Fig. S1). This in-
house web application is able to eﬃciently identify polyketide and
nonribosomal peptide gene clusters from bacterial genomes, compare
them to known biosynthetic gene clusters, and predict the struc-
tures of their small molecule products. We used PRISM to analyze
34 sequenced Legionella genomes – including 15 L. pneumophila
strains – revealing a diverse array of NRPS, PKS, and hybrid bio-
synthetic gene clusters (Fig. 1). From our sample of 34 genomes, we
identiﬁed 141 biosynthetic gene clusters related to nonribosomal
peptides (46), polyketides (7), or hybrid (88) systems, with an average
of 4 biosynthetic gene clusters per genome. In addition to the raw
number of hybrid assembly systems found in Legionella genomes,
these clusters were also the most diverse, with 18 distinct hybrid
biosynthetic gene clusters from these 34 genomes, compared to 13
distinct nonribosomal peptide gene clusters and only 3 purely
polyketide gene clusters. In sharp contrast to the massive canoni-
cal assembly line architectures,15 biosynthetic assembly lines in
Legionella are highly fragmented and small, with many comprised
of individual domains or lone multi-domain modules. This was par-
ticularly pronounced for nonribosomal peptide gene clusters, which
nearly always possessed only a single monomer-activating
adenylation domain (11 of 13). The majority of Legionella polyketide
synthases, either in pure polyketide systems or in hybrid systems,
were fully or partially trans-AT25 (14 of 21), where the monomer-
loading acyl transferase enzyme is sourced from outside the multi-
domain assembly line. Although trans-AT polyketide synthases are
becoming less rare with continued sequencing, Legionella has an
unusual twist, in that nearly all of the trans-AT systems do not have
an associated acyltransferase in the biosynthetic gene cluster, which
is exceptionally rare.26 In addition to the unusual organization, size,
and monomer-loading strategies of these biosynthetic clusters, they
also possess a large number of non-canonical termination mecha-
nisms. In canonical multi-domain assembly line polyketide or
nonribosomal peptide biosynthesis the small molecule chain is re-
leased from the enzyme assembly line via thioester hydrolysis
through a C-terminal thioesterase domain.15 Although thioesterases
are still the most abundant chain release enzyme (12 of 33 com-
plete clusters), most Legionella biosynthetic gene clusters do not
possess thioesterases, and instead appear to rely on NADH-dependent
reductases27 (5 of 33) or condensation domains (9 of 33), the latter
of which are exceptionally rare in described bacterial polyketide and
nonribosomal peptide biosynthetic gene clusters.28–30 Most notably,
many gene clusters did not possess analogs of any of these estab-
lished chain release enzymes, suggesting alternative means of
terminating thio-template natural product biosynthesis.
During this bioinformatic analysis, we did not uncover any bio-
synthetic gene clusters thatwere substantially similar to established
or sequenced gene clusters fromother bacteria, including fromwell-
studiedgenera suchas Streptomycesor relatively closely relatednatural
product producers, such as Pseudomonas. Despite the unusual ar-
chitecture of most of these biosynthetic gene clusters –which often
lack conventionalmonomer-loadingor chain-releaseenzymes–many
of these assemblages can be found in different species and appear
to be well-conserved. Legionella is known to have a patchwork
genome,31 which rapidly sheds and acquires genes in accordance
with survival needs,32 suggesting that these conserved unconven-
tional biosynthetic gene clusters are likely still functional.Moreover,
transcriptomics studies in L. pneumophila have demonstrated that
thesebiosynthetic geneclusters are transcriptionally active inavariety
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of culture conditions.33,34 To assess whether any of these unusual
gene clusters produced new natural product scaffolds, we chose to
pursue a genomic and metabolomic strategy with the genetically-
tractable L. pneumophila strain LP02.
3.2. Genetic and metabolic proﬁling of L. pneumophila uncovers a
novel natural product
We constructed a series of genetic knockouts in L. pneumophila
strain LP02, targeting ketosynthases in each of the 3 hybrid
polyketide-nonribosomal peptide gene clusters visible in the genome
(Fig. 2, Table 1, Tables S1 and S2). Each of these gene clusters is well-
conserved in L. pneumophila, represented in nearly all of the 15
complete or partially-sequenced strain genomes. However, each
cluster has a highly unusual architecture, as two (represented by
Δlpg1939 and Δlpg2228) are composed exclusively of individual bio-
synthetic domains and lack chain terminating enzymes, while the
third (represented by Δlpg2186) encodes a minimal NRPS and trans-
AT PKS without an apparent trans-acting acyltransferase present in
the genome. Following insertional activation, we observed that de-
letion of a ketosynthase (Δlpg2228) in one of these minimal gene
clusters caused a loss of sliding motility, indicating the produc-
tion of a surfactant, consistent with a previousmicrobiological study35
(Fig. 3A).
To identify polyketides or nonribosomal peptides associated with
the identiﬁed gene clusters, we used a comparative metabolomic
strategy. All L. pneumophila LP02wild type and knockout strains were
grown in rich or chemically deﬁned media until several days past
maturity, before cell pellets were collected by centrifugation and
extracted with methanol, and supernatants were extracted with ab-
sorbent HP20 resin. Cell pellet and supernatant extracts were pooled
and processed for small molecule contents using liquid chroma-
tography paired with mass spectrometry (LCMS). Data ﬁles and
chromatograms were analyzed to identify distinguishing molecu-
lar features between varying genetic backgrounds using Bruker
MetaboliteDetect and ProﬁleAnalysis software, which enabled com-
prehensive chromatographic analysis and principal component
analysis (PCA) respectively. The results of these analyses indicated
no metabolomic differences between Δlpg2186, Δlpg1939, and wild
type LP02. However, the Δlpg2228 mutant was shown to have sig-
niﬁcant metabolomic deviations from both wild type and the other
mutants (Fig. 3B, Fig. S2). This strain had previously been
L. shakespearei
1 8
L. pneumophila complex NRPS / PKS gene clusters
L. pneumophila
L. moravica
L. drancourtii
L. longbeachae
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L. anisa
L. dumoffii
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L. oakridgensis
L. micdadei
L. fairfieldensis
Fig. 1. PRISM analysis reveals that Legionella is a diverse genus with conserved biosynthetic potential. PRISM was used to identify polyketide and nonribosomal peptide
gene clusters in 34 sequenced Legionella genomes, which was conﬁrmed by manual inspection. PKS and NRPS gene clusters were sorted as a heat map and overlaid onto a
phylogenetic tree constructed using 16S rRNA sequences to highlight the conserved biosynthetic potential of Legionella.
lpg2225 lpg2232
1kb
lpg2186lpg2177
lpg1936 lpg1943
lpg2228
lpg1939
Fig. 2. Hybrid polyketide-nonribosomal peptide gene clusters of Legionella pneumophila targeted for mutagenesis. PRISM identiﬁed three hybrid PKS-NRPS gene clusters in
the genome of L. pneumophila LP02, roughly deﬁned as lpg1936-lpg1943, lpg2177-lpg2186, and lpg2225-lpg2232. Ketosynthases in each gene cluster were insertionally
inactivated by insertion of a kanamycin resistance gene, disrupting expression of lpg1939, lpg2186, and lpg2228 (red).
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observed to be deﬁcient in sliding motility (Fig. 3A), and appears
to lack a series of metabolites which would correspond to the absent
surfactant and biosynthetic intermediates. This series was present
in all other biosynthetic mutants, which likewise showed no devi-
ation from the wild type sliding colony phenotype, indicating that
the unusual and minimal gene cluster associated with these me-
tabolites likely does not rely on polyketide-derived precursors
supplied in trans, at least not from the identiﬁed gene clusters. Al-
though these surfactants ionize quite well, ionization intensity during
mass spectrometry is not necessarily correlated with high abun-
dance, and we found during initial isolation attempts that these
molecules were present in extremely low quantities.
Close analysis of our metabolites detected by comparative
metabolomics and PCA indicated two complexes of natural prod-
ucts (Fig. 4A), likely corresponding to a series of core metabolites
and acylated variants as indicated by an increased retention time
and mass, but highly similar MS/MS fragmentation (Fig. S3). Al-
though each unacylated compoundwas generally present as a single
predominant peak for eachmass, each acylatedmolecule was present
as three to ﬁve individual peaks, indicating considerable heteroge-
neity. In hopes of obtaining a pure compound for NMR structure
elucidation, we chose to isolate the most abundant core scaffold me-
tabolite (459.2 [M+H]+) through serial rounds of LCMS puriﬁcation
from 100 L of wild type LP02 culture. As a further demonstration
of the remarkably low abundance of this molecule, preparative scale
isolation yielded <500 μg of this metabolite. The structure of this
pure compound was then elucidated by a combination of 1D and
2D NMR experiments and high resolutionmass spectrometry, which
provided a deﬁnitive molecular formula of C23H42N2O7 (0.327 Δppm;
see Material and Methods). 1H, 1H-correlation spectroscopy (COSY)
identiﬁed a short chain acyl unit, a number of secondary alcohols,
one primary alcohol, and a system of four aromatic protons. Im-
portantly, this also revealed that a prominent 133 m/z [M+H]+
fragment observed during MS/MS was a 2,5-diaminopentane-1,3,4-
triol. 13C-amino acid feeding experiments demonstrated that this
hydroxylated diaminopentane was derived from ornithine (Fig. S4).
1H, 13C-heteronuclearmultiple-bond correlation spectroscopy (HMBC)
revealed a gem-di-methyl group between the phenol and primary
alcohol, and was used to link pieces identiﬁed with COSY, leading
to a highly unusual molecule that we named legionellol A (Fig. 4B;
Supplementary Note – Structure characterization). Reanalysis of the
legionellol series of metabolites identiﬁed through PCA indicated
at least 10 distinct chemical entities, including smaller, more hy-
drophilic legionellol variants which appear to have shorter acyl tails
or lack the gem-di-methyl. In addition, MS/MS revealed that a minor
series of legionellol variants likely possess an ornithine to argi-
nine substitution in themodiﬁed amino acid portion of themolecule,
and likewise possess a similar series of structural variations. Im-
portantly, acylated forms of legionellol could also be observed, and
MS/MS indicates that these are modiﬁed with a hydroxy-fatty acid,
primarily C12 and C14 (Fig. S3). To determine whichmolecular species
was responsible for sliding motility, a 10 μg sample of an acyl
legionellol or legionellol A was dried onto a 0.5% agar plate (as well
as methanol alone), and the Δlpg2228 strain was deposited on top.
The results of the corresponding outgrowth indicate that slidingmo-
tility was restored more effectively by supplementation with the
acylated legionellol, rather than the scaffold alone, indicating that
the variably acylated legionellol complex is likely the active sur-
factant (Fig. 4C).
Legionellol is a novel natural product which arises from aminimal
gene cluster composed of discrete domains often associated with
polyketide biosynthesis (Fig. 2; Table 1). From this gene cluster,
enzymes can be identiﬁed which appear responsible fatty acid
adenylation and CoA-ligation, and for the tethering, condensation,
reduction, and dehydration of polyketide extending units such as
malonate. However, genes required for several biosynthetic pro-
cesses – including chain release and generation of the modiﬁed
amino acid – are notably absent, suggesting that the enzymes re-
quired for these processes are located elsewhere in the genome, or
that these functions are performed by new classes of biosynthetic
enzymes. To assess whether unusual enzymesmay account for some
absent biosynthetic processes, we investigated an unusual GH3
Table 1
Genes of a Legionella pneumophila hybrid biosynthetic gene cluster (lpg2225-2234).
Gene name Locus tag Predicted function Strand Amino acids
lol1 lpg2225 GH3-family auxin responsive protein − 509
lol2 lpg2226 Isovaleryl CoA dehydrogenase − 563
lol3 lpg2227 Propionyl-CoA carboxylase − 479
lol4 lpg2228 3-oxoacyl-(acyl carrier protein) synthase III + 353
lol5 lpg2229 Acyl CoA synthetase + 581
lol6 lpg2230 Acyl CoA ligase + 464
lol7 lpg2231 3-oxoacyl reductase + 250
lol8 lpg2232 3-oxoacyl-(acyl carrier protein) synthase III + 336
lol9 lpg2233 Acyl carrier protein − 75
lol10 lpg2234 Major facilitator superfamily eﬄux pump − 455
Wildtype Δlpg2228
A. B.
0 10 20 30 40 50 Time [min]
I x
109
wt
Δlpg2228
wt-specific
Fig. 3. Mutations in a hybrid polyketide gene cluster result in motility and metabolomic alterations. (A) Extended growth of Legionella pneumophila LP02 on 0.5% agar plates
results in pronounced sliding motility, which is absent in the Δlpg2228 strain. (B) Comparative metabolomic analysis of wild type and Δlpg2228 cultures with LCMS high-
lights a series of molecules which are absent in Δlpg2228.
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family protein that was present in one of the two operons in the
legionellol gene cluster, and which we suspected may be involved
with attaching the modiﬁed ornithine residue. GH3 family pro-
teins are known from plants, where they act as indole-3-acetic acid
amido-synthetases during auxin biosynthesis.36 More speciﬁcally,
these enzymes use ATP to adenylate a free carboxylic acid before
catalyzing the displacement of the adenosine monophosphate by
a nucleophilic amine from a free amino acid. While this mecha-
nism is common in plants it has yet to be implicated in the
biosynthesis of bacterial secondary metabolites, despite occasion-
ally occurring in PKS biosynthetic gene clusters.37,38 To assess whether
this conspicuous enzyme was responsible for coupling the modi-
ﬁed ornithine to the legionellol polyketide precursor, we generated
an insertionally inactivatedmutant using the same approach we had
demonstrated previously. Despite its presence in the legionellol bio-
synthetic operon, insertional inactivation of this unusual enzyme
did not alter legionellol production, although it remains to be seen
whether other unusual biosynthetic enzymes may play a role in the
construction of this novel natural product.
4. Discussion
Natural products have provided chemical scaffolds and molec-
ular innovation that has driven drug discovery and development
efforts for the last century.1 Despite their inherent value, rediscov-
ery of known natural products has led to declining discovery rates
and a loss in industrial interest.6 By pursuing challenging bacteria
that had not been previously studied as natural products produc-
ers, we reasoned that we could identify new, exotic chemistry arising
from novel biosynthetic gene clusters. In this work, we used bio-
informatics and advanced natural products chemistry techniques
to investigate Legionella as a source of novel natural product scaf-
folds, yielding the new molecule legionellol A.
Legionella is a diverse genus, and relatively limited genome se-
quencing has revealed species with signiﬁcant biosynthetic potential.
In this work, we chose to use the genetically-tractable L. pneumophila
strain LP02 to pursue a knockout and comparative metabolomics
approach to discover new molecules. However, the L. pneumophila
complex is not the most impressive candidate for natural product
discovery, as species related to L. dumoﬃi and L. longbeachae typi-
cally possess at least twice the number of biosynthetic gene clusters
present in L. pneumophila. Lone representative genomes of more
exotic Legionella spp. such as L. micdadei and L. shakespearei also in-
dicate that more extensive sequencing will reveal substantial
numbers of new biosynthetic gene clusters from these unex-
plored organisms, as both species possess large and unique hybrid
assembly lines. Using PRISM, we can now rapidly proﬁle emer-
gent genomes from this promising genus, identify biosynthetic gene
clusters automatically, and prioritize candidates for discovery in the
hopes of continuing to reveal interesting new natural products.
Although the rules for polyketide and nonribosomal peptide bio-
synthesis are well deﬁned, exotic organisms often deviate from
established systems.16,18 Legioliulin, the only example of a polyketide
(or nonribosomal peptide) known from Legionella prior to this study,
highlights several biosynthetic oddities that frequently occur in
Legionella biosynthetic gene clusters, including a propensity for trans-
AT PKS logic that does not include an associated acyl transferase.26
This situation is more bizarre in L. pneumophila, which has three
hybrid polyketide and nonribosomal peptide gene clusters, but only
has a single malonyl-acyltransferase (lpg1394), which is associ-
ated with the fatty acid synthase operon, suggesting that there may
be an alternativemonomer loading strategy to create polyketideme-
tabolites such as legionellol. Legionella also possesses a number of
unusual chain termination strategies, including the use of C-terminal
condensation domains to facilitate trans-esteriﬁcation and thioester
cleavage, which had only been reported previously in a handful of
bacterial natural products, including the Myxobacterial natural
product crocacin,30 FK520,28 and the C-1027 enediyne.29 The fre-
quency of these unusual biosynthetic domains, combined with the
unorganized lone-domain structure of Legionella’s biosynthetic gene
clusters, limits the predictability of their polyketide and
nonribosomal peptide products. This is well illustrated by legionellol,
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Fig. 4. An unusual PKS gene cluster in Legionella pneumophila encodes for legionellol, a novel surfactant scaffold. (A) Metabolites absent from Δlpg2228 appear to separate
as two complexes by LCMS, comprised of a smaller hydrophilic series of metabolites, and a larger hydrophobic series of metabolites. The most abundant of these hydro-
philic scaffold molecules – legionellol A – is indicated with an arrow. (B) Structure of the novel L. pneumophila surfactant legionellol A as deduced by NMR andMS experiments.
(C) To assess the impact of legionellol metabolites on sliding motility, 10 μL of Δlpg2228 overnight culture was added to a 0.5% agar BCYE plate alone, or over top of dried
10 μL drops of methanol, 1 μg/μL acyl legionellol (684 Da), or 1 μg/μL legionellol A. Plates were grown for one week at 30 °C, and demonstrate that acyl legionellol is able
to recapitulate sliding motility. Scale bars are equal to 5 mm.
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which is a remarkably complex natural product that arises from a
seemingly simple biosynthetic gene cluster. Given its unusual struc-
ture andminimal biosynthetic gene cluster, the precise biosynthetic
pathway of legionellol is still unclear, but the origins of some units
can be speculated. Generation of the modiﬁed ornithine residue
would require hydroxylation of the ornithine β- and γ-carbons, fol-
lowed by activation of the carboxylic acid and iterative reduction
to the observed alcohol. How the putative polyketide portion of
legionellol is constructed is much less clear, and must include a
number of exotic monomers and transformations. Construction of
the polyketide likely begins with activation of a short-chain fatty
acid of varying length, giving rise to the observed range of legionellol
variants. Chain elongation with glycerate-derived hydroxymalonate
followed by ketoreduction could then result in the hydroxylated acyl
chain. Beyond this however, biosynthetic processes involved in con-
structing legionellol or its monomers become diﬃcult to predict,
such as the origins of the unusual primary alcohol and neighbor-
ing gem-dimethyl. Hopefully, further study of this promising genus
may reveal innate biosynthetic logic involved in creating both
legionellol and other unique natural products, facilitating predic-
tion and discovery of new chemical scaffolds.
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